HELIOS-BCL11B fusion gene involvement in a t(2;14)(q34;q32) in an adult T-cell leukemia patient

Cancer Genetics

Volumn 205, Issue 7-8, 2012, Pages 356-364

  Fujimoto, Rika ^a   Ozawa, Tatsuhiko ^a   Itoyama, Takahiro ^b   Sadamori, Naoki ^c   Kurosawa, Nobuyuki ^a   Isobe, Masaharu ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b IMAMURA BUN IN HOSPITAL   (Japan)

^c UNIVERSITY OF NAGASAKI   (Japan)

Author keywords

ATLL; BCL11B; Fusion transcript; HELIOS; Translocation

Indexed keywords

B CELL LYMPHOMA 11B PROTEIN; HELIOS PROTEIN; HYBRID PROTEIN; MESSENGER RNA; METASTASIS ASSOCIATED PROTEIN 2; TRANSCRIPTION FACTOR GATA; TUMOR PROTEIN; UNCLASSIFIED DRUG; BCL11B PROTEIN, HUMAN; IKAROS TRANSCRIPTION FACTOR; IKZF2 PROTEIN, HUMAN; PRIMER DNA; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

5' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; ARTICLE; B CELL LYMPHOMA 11B GENE; BINDING SITE; CHROMOSOME; CHROMOSOME 32Q; CHROMOSOME 34Q; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 2; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; FUSION GENE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; HELIOS GENE; HUMAN; HUMAN CELL; INTRON; LEUKEMIA CELL; MOLECULAR CLONING; MOLECULAR PATHOLOGY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECIPROCAL CHROMOSOME TRANSLOCATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LEUKEMIA; WILD TYPE; ADULT; CASE REPORT; CHROMOSOME 14; CHROMOSOME 2; FLUORESCENT ANTIBODY TECHNIQUE; GENE FUSION; GENE TRANSLOCATION; GENETICS; SOUTHERN BLOTTING; TUMOR CELL CULTURE;

ADULT; BASE SEQUENCE; BLOTTING, SOUTHERN; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 2; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; GENE FUSION; HUMANS; IKAROS TRANSCRIPTION FACTOR; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, T-CELL; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 84867144924     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.04.006     Document Type: Article

References (30)

1. Hinuma Y., Komoda H., Chosa T., et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int J Cancer 1982, 29:631-635.
2. Matsuoka M., Jeang K.T. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007, 7:270-280.
3. Koizumi S., Iwanaga M., Imai S., et al. Expression of myeloid cell phenotypes by a novel adult T-cell leukemia/lymphoma cell line. J Natl Cancer Inst 1992, 84:690-693.
4. Tricarico M., Macchi B., D'Atri S., et al. In vitro infection of CD4+ T lymphocytes with HTLV-I generates immortalized cell lines coexpressing lymphoid and myeloid cell markers. Leukemia 1999, 13:222-229.
5. Rabbitts T.H. Chromosomal translocations in human cancer. Nature 1994, 372:143-149.
6. Itoyama T., Chaganti R.S., Yamada Y., et al. Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki. Blood 2001, 97:3612-3620.
7. Narducci M.G., Virgilio L., Isobe M., et al. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood 1995, 86:2358-2364.
8. Saitou M., Sugimoto J., Hatakeyama T., et al. Identification of the TCL6 genes within the breakpoint cluster region on chromosome 14q32 in T-cell leukemia. Oncogene 2000, 19:2796-2802.
9. Sugimoto J., Hatakeyama T., Narducci M.G., et al. Identification of the TCL1/MTCP1-like 1 (TML1) gene from the region next to the TCL1 locus. Cancer Res 1999, 59:2313-2317.
10. Arlotta P., Molyneaux B.J., Chen J., et al. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 2005, 45:207-221.
11. Arlotta P., Molyneaux B.J., Jabaudon D., et al. Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum. J Neurosci 2008, 28:622-632.
12. Golonzhka O., Leid M., Indra G., et al. Expression of COUP-TF-interacting protein 2 (CTIP2) in mouse skin during development and in adulthood. Gene Expr Patterns 2007, 7:754-760.
13. Przybylski G.K., Dik W.A., Wanzeck J., et al. Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005, 19:201-208.
14. Wakabayashi Y., Inoue J., Takahashi Y., et al. Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun 2003, 301:598-603.
15. Isobe M., Russo G., Haluska F.G., et al. Cloning of the gene encoding the delta subunit of the human T-cell receptor reveals its physical organization within the alpha-subunit locus and its involvement in chromosome translocations in T-cell malignancy. Proc Natl Acad Sci U S A 1988, 85:3933-3937.
16. Southern E.M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975, 98:503-517.
17. Ozawa T., Kondo M., Isobe M. 3' rapid amplification of cDNA ends (RACE) walking for rapid structural analysis of large transcripts. J Hum Genet 2004, 49:102-105.
18. Cismasiu V.B., Adamo K., Gecewicz J., et al. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. Oncogene 2005, 24:6753-6764.
19. Nagel S., Kaufmann M., Drexler H.G., et al. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res 2003, 63:5329-5334.
20. Pekarsky Y., Hallas C., Croce C.M. The role of TCL1 in human T-cell leukemia. Oncogene 2001, 20:5638-5643.
21. Gesk S., Martin-Subero J.I., Harder L., et al. Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia 2003, 17:738-745.
22. Tabayashi T., Ishimaru F., Takata M., et al. Characterization of the short isoform of Helios overexpressed in patients with T-cell malignancies. Cancer Sci 2007, 98:182-188.
23. Zhang Z., Swindle C.S., Bates J.T., et al. Expression of a non-DNA-binding isoform of Helios induces T-cell lymphoma in mice. Blood 2007, 109:2190-2197.
24. Bezrookove V., van Zelderen-Bhola S.L., Brink A., et al. A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. Cancer Genet Cytogenet 2004, 149:72-76.
25. Grabarczyk P., Przybylski G.K., Depke M., et al. Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene 2007, 26:3797-3810.
26. Kamimura K., Mishima Y., Obata M., et al. Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages. Oncogene 2007, 26:5840-5850.
27. Oshiro A., Tagawa H., Ohshima K., et al. Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma. Blood 2006, 107:4500-4507.
28. Su X.Y., Busson M., Della Valle V., et al. Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukemia. Genes Chromosomes Cancer 2004, 41:243-249.
29. Getnet D, Grosso JF, Goldberg MV, et al. A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells. Mol Immunol;47:1595-1600.
30. Vanvalkenburgh J, Albu DI, Bapanpally C, et al. Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease. J Exp Med;208:2069-2081.